PDX Portal

Model Details

Patient Information for Model: BCM-PDAC-1

Model Contact

Model: BCM-PDAC-1
Model Contact: Qizhi Cathy Yao
Institution: BCM Pancreas PDX Program
Email: qizhiyao@bcm.edu

Patient Information

Clinical Timeline

Clinical Information at Collection

Clinical Biomarkers/Mutations at Collection

Pathology Information at Collection

Model Information for Model: BCM-PDAC-1

Model Details - Initial Implantation of Patient Tissue

Mutations (Cancer Gene Census List)

Mutation data is currently not available.

CNV

Histology Information for Model: BCM-PDAC-1

There are no histology images for this model.

Metastasis Information for Model: BCM-PDAC-1

Patient

PDX

Liver

Local recurrence

Lung

Rectum

lymph node

Patient Treatment Information for Model: BCM-PDAC-1

Event Id	Treatment	Treatment Setting	Age at Start	Age at End	Duration	Clinical Response	Pathologic Response	Reason Stopped
10	Gemcitabine/Abraxane	Neoadjuvant	58.54	58.64	37 days	Complete Response (CR)	No Response (NR)	Treatment completed
20	Gemcitabine	Adjuvant	59.03	59.17	51 days	Partial Response (PR)	Unknown	Treatment completed
25	Capecitabine/radiation	Adjuvant	59.17	59.33	58 days	Partial Response (PR)	Unknown	Treatment completed